Ken Fisher's position in Abbott Laboratories is currently worth $1.06 Billion. That's 0.54% of their equity portfolio (52nd largest holding). The first Abbott Laboratories trade was made in Q1 2013. Since then Ken Fisher bought shares 30 more times and sold shares on thirteen occasions. The stake costed the investor $930 Million, netting the investor a gain of 14% so far.
SAN FRANCISCO , March 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, toda...
Benzinga, about 2 years agoCardiac Biomarkers Market: Overview The solution from the cardiac biomarkers market prevents cardiac disease by effective monitoring of heart conditions. For...
OpenPR, over 2 years agoThe global Autoimmune Disease Diagnostics Market size is expected to grow from USD 6.3 billion by 2028 from USD 4.1 billion in 2021, at a CAGR of +8%. A rese...
OpenPR, over 2 years agoKey Distinguished Gamers Lined within the Infectious Illness Level of Care Diagnostics Market Analysis Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerlan...
Business Blog Daddy, over 2 years ago